{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-331594","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2026-08-04T12:05:06+00:00","discovered_at":"2026-08-04T12:10:00.369635+00:00","generated_at":"2026-08-04T12:10:31.669723+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Rani Therapeutics appoints Michelle Gilson to Board of Directors, as Audit Committee chair","bullets":["Michelle Gilson appointed to Board effective August 1, 2026; also named chair of Audit Committee.","Gilson, 34, was CFO of Arcellx until its acquisition by Gilead in April 2026.","Prior roles include Senior Biotechnology Equity Research Analyst at Canaccord Genuity (Managing Director) and earlier at Jefferies, Nomura, Oppenheimer, Goldman Sachs.","She will receive compensation per company's Non-Employee Director Compensation Policy; standard indemnification agreement.","No arrangements, family relationships, or material interests in transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-331594","json":"https://secwatch.observer/filing/0001193125-26-331594.json","markdown":"https://secwatch.observer/filing/0001193125-26-331594.md","text":"https://secwatch.observer/filing/0001193125-26-331594.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000119312526331594/0001193125-26-331594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000119312526331594/d177572d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T12:10:31.669723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}